Anixa CEO buys 5,000 shares in open market

Anixa Biosciences Inc director and Chief Executive Officer Amit Kumar reported an open-market purchase of 5,000 shares of Common Stock on July 10, 2026 at $3.04 per share.

Rhea-AI Filing Summary

Anixa Biosciences Inc director and Chief Executive Officer Amit Kumar reported an open-market purchase of 5,000 shares of Common Stock on July 10, 2026 at $3.04 per share. Following this transaction, he directly holds a total of 635,812 shares of Anixa Biosciences common stock.

Filing Explained

This is an insider ownership increase, not a disclosed company financing: Amit Kumar bought 5,000 shares and reported 635,812 direct shares afterward.

The July 13 Form 4 reports that Amit Kumar, Anixa’s chief executive officer, bought 5,000 shares of common stock on July 10, 2026 at $3.04 per share.

After the transaction, the filing reports 635,812 shares held directly, so the disclosed structural effect is an increase in the filer’s reported ownership. Form 4 code P denotes an open-market purchase, and no Rule 10b5-1 trading plan disclosure appears in the supplied filing.

Insider Trade Summary

Net Buyer: 5,000 shares

Net Buy 1 txn

Insider KUMAR AMIT

Role Chief Executive Officer

Bought 5,000 shs ($15K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$3.04	$15K

Holdings After Transaction: Common Stock — 635,812 shares (Direct)

Key Figures

Shares Purchased: 5,000 shares Purchase Price: $3.04 per share Post-Transaction Holdings: 635,812 shares +1 more

4 metrics

Shares Purchased 5,000 shares Open-market purchase of Anixa Biosciences common stock on July 10, 2026

Purchase Price $3.04 per share Price paid for 5,000 Anixa Biosciences common shares

Post-Transaction Holdings 635,812 shares Total Anixa Biosciences common stock directly held by Amit Kumar after the trade

Net Buy Shares 5,000 shares Net buy direction across all reported transactions in this Form 4

Key Terms

open-market purchase, transaction code, Common Stock

3 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

transaction code financial

"transaction_code: "P" with transaction_code_description"

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Anixa Biosciences (ANIX) CEO Amit Kumar report in this Form 4?

Amit Kumar reported an open-market purchase of Anixa Biosciences common stock. He bought 5,000 shares at $3.04 per share, increasing his direct holdings to 635,812 shares after the transaction on July 10, 2026.

How many ANIX shares did Amit Kumar buy and at what price?

Amit Kumar bought 5,000 shares of Anixa Biosciences common stock. The Form 4 shows a transaction price of $3.04 per share for this open-market purchase completed on July 10, 2026.

What is Amit Kumar’s total ANIX shareholding after this transaction?

After the reported transaction, Amit Kumar directly holds 635,812 shares of Anixa Biosciences common stock. This figure reflects his post-transaction position as disclosed in the Form 4 filing for the July 10, 2026 purchase.

Was the Anixa Biosciences (ANIX) insider trade a buy or a sell?

The reported insider trade was a buy. The Form 4 classifies the transaction as an open-market purchase of 5,000 shares of Anixa Biosciences common stock at $3.04 per share by CEO Amit Kumar.

What transaction code is used for Amit Kumar’s ANIX stock trade?

The Form 4 uses transaction code P for Amit Kumar’s trade. Code P denotes a purchase in an open market or private transaction, matching the 5,000-share acquisition of Anixa Biosciences common stock at $3.04 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 08:59 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KUMAR AMIT

(Last) (First) (Middle)

C/O ANIXA BIOSCIENCES, INC.

3150 ALMADEN EXPRESSWAY, SUITE 250

(Street)

SAN JOSE CALIFORNIA 95118

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anixa Biosciences Inc [ ANIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		P		5,000	A	$3.04	635,812	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Amit Kumar	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)